No Images? Click here LUNGevity welcomes Jennifer Kashatus to Board of DirectorsJennifer Kashatus, a longtime privacy and cybersecurity professional and partner at DLA Piper LLP, has joined LUNGevity’s Board of Directors. She assists companies in developing comprehensive global and domestic privacy and data security programs and guiding companies in navigating the myriad state, federal, and international privacy regulations. Jennifer brings extensive volunteer experience in the Washington, DC, area. She also brings wide-ranging business experience to support LUNGevity’s strategic growth and guide LUNGevity on partnering opportunities in many areas. Learn more about Jennifer on our website. LUNGevity’s patient research to be presented at international conferenceFour of LUNGevity’s research projects have been accepted to the prestigious World Conference on Lung Cancer. Organized by the International Association for the Study of Lung Cancer (IASLC), the conference will be held in Toronto, Canada in September 2018. The accepted abstracts present new understandings on topics that are specific to the needs of lung cancer patients. These studies were conducted through Patient FoRCe, LUNGevity’s patient-focused research center, which seeks to ensure that patient voices are heard and incorporated into healthcare decisions. LUNGevity staff will give presentations on topics including:
Stay tuned for a World Lung wrap-up in October! Five ways to improve communication with your medical teamLUNGevity Scientific Advisory Board Member Lecia Sequist, MD, and nurse practitioner Elizabeth Krueger, MSN, both of Massachusetts General Hospital, spoke with LUNGevity to provide tips on ways patients can better communicate with their medical team. Get the tips, get additional resources, and more here! LUNGevity hires new Director of Precision Medicine InitiativesLUNGevity is pleased to strengthen its commitment to improving patient access to targeted therapies by welcoming Nicole (Nikki) Martin, a longtime healthcare and diagnostic professional, as its Director of Precision Medicine Initiatives. Nikki will manage LUNGevity’s precision medicine efforts, including the Take Aim initiative. The Take Aim initiative works to ensure that patients have access to biomarker testing and that it is reimbursed in order to help guide their treatment decisions in a timely way. Nikki will also form coalitions to break down silos to improve patient and healthcare provider education and patients’ access to precision medicines. Nikki Martin has worked on healthcare issues advocacy for more than 15 years. Prior to joining LUNGevity, Nikki worked in Alliance & Advocacy Relations at Genentech, where she championed awareness of unmet needs and driving change in the patient community. LUNGevity to attend Stand Up To Cancer telecastLUNGevity will be attending the Stand Up To Cancer telecast on Friday, September 7, celebrating 10 years of making an impact with groundbreaking cancer research. LUNGevity is partnering with SU2C and the American Lung Association’s LUNG FORCE on two teams to intercept lung cancer at its earliest stage. Exciting upcoming eventsBreathe Deep walksThere are Breathe Deep Walks taking place across the country this fall. People living with lung cancer are joined by family, friends, and advocates each year to walk, run, and volunteer to raise money and awareness for lifesaving research, education, and support. Find an event near you.
Team LUNGevity eventsTeam LUNGevity is still looking for runners! Sign up here to run the Marine Corps Marathon on October 28 in Washington, DC. Interested in other endurance events? Raise funds for lung cancer research and support at any race when you join Team LUNGevity! We have all the online tools you need. Celebration of Hope Gala set for November 1LUNGevity will host its sixth annual Celebration of Hope Gala at the Mandarin Oriental Hotel in NYC on Wednesday, November 1. The gala works to recognize the hope in lung cancer research and raise critical funds for lung cancer research as well as education and support programs, which benefit patients, survivors, and caregivers. Learn more about the gala here. International Lung Cancer Survivorship ConferenceLUNGevity is excited to announce the inaugural International Lung Cancer Survivorship Conference. In 2019, LUNGevity will expand the keystone HOPE Summit survivorship summit to a full-blown conference, the International Lung Cancer Survivorship Conference (ILCSC). LUNGevity's ILCSC brings together lung cancer survivors in all stages of the disease and diagnosis with scientific experts, nutritionists, clinicians, health care providers, and fellow survivors to learn how to live well with lung cancer. The conference will be composed of three tracks: the HOPE Summit, the COPE Summit, and the Survivorship Summit. More details on this to follow; stay tuned! |